These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 28823747

  • 21. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y, Grant C, Xie K, Sweiss NJ.
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [Abstract] [Full Text] [Related]

  • 22. Prognostic value of phase analysis on gated single photon emission computed tomography in patients with cardiac sarcoidosis.
    Koyanagawa K, Naya M, Aikawa T, Manabe O, Kuzume M, Ohira H, Tsujino I, Tamaki N, Anzai T.
    J Nucl Cardiol; 2021 Feb; 28(1):128-136. PubMed ID: 30815835
    [Abstract] [Full Text] [Related]

  • 23. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
    Trivieri MG, Robson PM, Vergani V, LaRocca G, Romero-Daza AM, Abgral R, Devesa A, Azoulay LD, Karakatsanis NA, Parikh A, Panagiota C, Palmisano A, DePalo L, Chang HL, Rothstein JH, Fayad RA, Miller MA, Fuster V, Narula J, Dweck MR, Morgenthau A, Jacobi A, Padilla M, Kovacic JC, Fayad ZA.
    JACC Cardiovasc Imaging; 2024 Apr; 17(4):411-424. PubMed ID: 38300202
    [Abstract] [Full Text] [Related]

  • 24. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
    Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, Hainer J, Murthy VL, Skali H, Dorbala S, Di Carli MF, Blankstein R.
    J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
    [Abstract] [Full Text] [Related]

  • 25. The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.
    Patel VN, Pieper JA, Poitrasson-Rivière A, Kopin D, Cascino T, Aaronson K, Murthy VL, Koelling T.
    J Nucl Cardiol; 2022 Oct; 29(5):2460-2470. PubMed ID: 34505261
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy of myocardial washout of 99mTc-MIBI/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis: comparison with 18F-fluorodeoxyglucose positron emission tomography findings.
    Suzuki M, Izawa Y, Fujita H, Miwa K, Takahashi Y, Toh H, Toba T, Fujiwara S, Hashimura H, Kono AK, Hirata KI.
    Ann Nucl Med; 2022 Jun; 36(6):544-552. PubMed ID: 35303274
    [Abstract] [Full Text] [Related]

  • 30. The Utility of Whole Body 18F-FDG PET-CT in Diagnosing Isolated Cardiac Sarcoidosis: The Western Australian Cardiac Sarcoid Study.
    Giudicatti L, Marangou J, Nolan D, Dembo L, Baumwol J, Dwivedi G.
    Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.
    Lebasnier A, Legallois D, Bienvenu B, Bergot E, Desmonts C, Zalcman G, Agostini D, Manrique A.
    Ann Nucl Med; 2018 Jun; 32(5):319-327. PubMed ID: 29560563
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
    Shelke AB, Aurangabadkar HU, Bradfield JS, Ali Z, Kumar KS, Narasimhan C.
    Int J Cardiol; 2017 Feb 01; 228():717-722. PubMed ID: 27886616
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.
    Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, Govender P, Ruberg FL, Miller EJ.
    J Nucl Cardiol; 2014 Oct 01; 21(5):925-39. PubMed ID: 24879453
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    Gowani Z, Habibi M, Okada DR, Smith J, Derakhshan A, Zimmerman SL, Misra S, Gilotra NA, Berger RD, Calkins H, Tandri H, Chrispin J.
    Am J Cardiol; 2020 Nov 01; 134():123-129. PubMed ID: 32950203
    [Abstract] [Full Text] [Related]

  • 40. Novel ECG parameters are strongly associated with inflammatory 18F-FDG PET findings in patients with suspected cardiac sarcoidosis.
    Sipilä K, Tuominen H, Haarala A, Tikkakoski A, Kähönen M, Nikus K.
    Int J Cardiol; 2017 Dec 15; 249():454-460. PubMed ID: 29121750
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.